期刊文献+

乌司他丁对心脏瓣膜置换手术患者肝功能的影响

下载PDF
导出
摘要 目的 探讨体外循环(CPB)心脏瓣膜置换手术中应用乌司他丁(UTI)对机体肝功能的影响。方法 将行心脏瓣膜置换手术的60例患者随机分为两组,实验组转机前给予乌司他丁30万U置入预充液中随机转入体内,术后第1、2、3天每天给予5%葡萄糖液250ml加乌司他丁30万U静脉滴注;对照组不用乌司他丁,而给予等量生理盐水。实验组和对照组均在术前1 d,术后第1,3,5,7天测定血清总胆红素(TBiL)、天门冬氨酸氨基转移酶(AST)、丙氨酸氨基转移酶(ALT)、y-谷氨酰转肽酶(y—GT)。结果手术前两组病人TBiL、AST、ALT、y-GT间差异无统计学意义(P〉0.05)。CPB结束后,两组病人TBiI、AST、ALT、y—GT均分别高于手术前(P〈0.05),但实验组TBiL、AST、ALT、y-GT均分别低于对照组(P〈0.05)。结论乌他司丁对心脏瓣膜置换手术病人肝功能有保护作用。
出处 《中原医刊》 2008年第7期49-50,共2页 Central Plains Medical Journal
基金 基金项目:广西壮族自治区卫生厅自筹经费科研课题(E2007284)
  • 相关文献

参考文献7

  • 1孙宇,彭宝岗.乌司他丁治疗重症急性胰腺炎的疗效对比[J].中原医刊,2006,33(23):29-29. 被引量:1
  • 2Ambiru SM,Miyazaki M. Effects of preoperative protease inhibitor on inflammatory cylokines and acute - phase proteins in patients with hepatic resection[J].Dig Surg,2000,17 (4) :337 - 343.
  • 3Jaeschke H, Smith CW. Meehanism of neutrophil - induced paranchymal cell injury [ J ]. J Leuk Bio, 1997,61 ( 6 ) :647 - 653.
  • 4Sato Y, lshikawa S,Otaki A. Induction of acute -phase reactive substances during open - heart surgery, and efficacy of ulinastatin. Inhibiting cytokines and posloperative organ injury[ J]. Jpn J Thorac Cardiovasc Surg, 2000,48 ( 7 ) : 428 - 434.
  • 5Aosasa S, Oho S, Mochizuki H, et al. Mechanism of the inhibitory effect of protease inhibitor on tumor or necrosis or alpha production of monocytes[J].Sbock,2001,15(2) : 101 - 105.
  • 6林胜璋,郑志强,吴伟军,俞辉军,游涛,陈聪.乌司他丁对大鼠肝缺血-再灌流损伤的保护作用[J].中华急诊医学杂志,2005,14(5):388-390. 被引量:22
  • 7向强,杨小文,董爱萍,王荣,王力甚.乌司他丁对成人先天性心脏病手术炎性反应的影响[J].中国体外循环杂志,2007,5(1):17-19. 被引量:19

二级参考文献21

  • 1侯晓彬,肖明第.全身炎症反应综合征与体外循环[J].中国体外循环杂志,2004,2(2):119-121. 被引量:19
  • 2[1]Sheeran P,Hall GM.Cytokines in anaesthesia[J].Br J Anaasth,1997,78(2):201 -219.
  • 3[2]Laffey JG,Boylan JF,Chexg DC.The systemic inflammatory respense to cardiac surgery:implications for the Anesthesiologist[J].Anesthesiology,2002,97(1):215 -252.
  • 4[3]Davies SW,Duffy JP,Wickens DG,et al.Time-course of free radical activity during coronary artery operations with cardiopulmonary bypass[J].J Thorac Cardiovasc Surg,1993,105 (6):979-987.
  • 5[5]Atkins MB.tnterleukin -2:clinical applications[J].Semin Oncol,2002,29 (3 suppl 7):12-17.
  • 6[6]Stordeur P,Goldman M.Interleukin-10 as a regulatory cytokine induced by cellular stress:molecular aspects[J].Int Rev Immunol,1998,16(5 -6):501 -522.
  • 7[7]McBride WT,Armstrong MA,Crockard AD,et al.Cytokine balance and immunosuppressive changes at cardiac surgery:Contrasting response between patients and isolated CPB circuits[J].Br J Anaesth,1995,75 (6):724-733.
  • 8[8]Kawamura T,Wakausawa R,Okada K,et al.Elevation of cytokines during open heart surgery with cardiopulmonary bypass:Participation of interleukin 8 and 6 in reperfusion injury[J].Can J Anaesth,1993,40 (11):1016-1021.
  • 9[9]Journois D,Israel -Biet D,Pouard P,et al.High volume,zero balanced hemofiltration to reduce delayed inflammatory response to cardiopulmonary bypass in children[J].Anesthesiology,1996,85 (5):965-976.
  • 10[10]Sato Y,Ishikawa S,Otaki A.Induction of acute-phase reactive substances during open-heart surgery and efficacy of ulinastatin.Inhibiting cytokines and postoperative organ injury[J].Jpn J Thorac Cardiovasc Surg,2000,48 (7):428-434.

共引文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部